Treatment of statin side effects

Details for Australian Patent Application No. 2002223302 (hide)

Owner Magral Limited

Inventors Linnane, Anthony William

Agent Davies Collison Cave

Pub. Number AU-B-2002223302

PCT Pub. Number WO02/43721

Priority PR1773 29.11.00 AU

Filing date 29 November 2001

Wipo publication date 11 June 2002

Acceptance publication date 31 August 2006

International Classifications

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

18 March 2004 Assignment before Grant

  Centre for Molecular Biology and Medicine The application has been assigned to Magral Pty Ltd

31 August 2006 Application Accepted

  Published as AU-B-2002223302

31 August 2006 Change of Name(s) of Applicant(s), Section 104

  Magral Pty Ltd The name of the applicant has been changed to Magral Limited

24 May 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002223303

2002223301-Probes for identifying cancer-specific antigens